InvestorsHub Logo
Followers 61
Posts 3376
Boards Moderated 1
Alias Born 12/26/2012

Re: JPetroInc post# 95622

Friday, 02/21/2014 9:26:16 PM

Friday, February 21, 2014 9:26:16 PM

Post# of 130508
JP.. Lincoln is very Toxic... no need to compare AMBS to a P&D in the middle of a pump..... and you forget Dominion helped AMBS pay off their Toxic debt

Gerald is following the plan for the Milestones, they added another Study to increase LymPro's Value..

Amarantus is pushing forward with a 7-year follow-up analysis of the 88 patients studied in the Phase 1 trial. This will be an incredibly important longitudinal analysis for the validation of LymPro and help management secure a development and commercialization partnership once completed.



http://seekingalpha.com/article/2027661-new-cash-to-help-drive-amarantus-pipeline